Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? | Journal of the American Heart Association
PDF) Oral Anticoagulation in Patients With Liver Disease
Oral Anticoagulation in Patients With Liver Disease - ScienceDirect
Nutrients | Free Full-Text | New Perspectives on the Effect of Dandelion, Its Food Products and Other Preparations on the Cardiovascular System and Its Diseases | HTML
A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome - ScienceDirect
Oral Anticoagulation in Patients With Liver Disease - ScienceDirect
S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis - Cellular and Molecular Gastroenterology and Hepatology
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants | Journal of the American College of Cardiology
Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study - Thrombosis Research
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? | Journal of the American Heart Association
Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment | Molecular Pharmaceutics
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma - ScienceDirect
Frontiers | “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
Ultraporous Polyquaternium-Carboxylated Chitosan Composite Hydrogel Spheres with Anticoagulant, Antibacterial, and Rapid Endotoxin Removal Profiles for Sepsis Treatment | Biomacromolecules
Anticoagulation in chronic liver disease - Journal of Hepatology
Frontiers | Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study
PDF) Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
Cells | Free Full-Text | Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? | HTML
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
PDF) Anticoagulation in the cirrhotic patient
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology
PDF) Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
Frontiers | Potential Effects of Coronaviruses on the Liver: An Update
Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19 - Clinical Gastroenterology and Hepatology
